Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Overton Tapped for FDA; Pharma Watches What Changes Next

U.S. President Donald Trump on August 19 named White House policy aide Heidi Overton to lead the Food and Drug Administration (FDA), months after former Commissioner Marty Makary resigned. Overton, a physician and deputy director of the White House Domestic
  • News
Overton Tapped for FDA; Pharma Watches What Changes Next

FDA Leadership Shake-Up; Permanent CDER and CBER Chiefs Could Shift Review Priorities

The FDA reportedly plans to appoint permanent leaders for CDER and CBER when the White House names its next commissioner nominee. This FDA leadership reset aims to stabilize two centers that shape major drug and biologics decisions. However, pharmaceutical companies
  • News
FDA Leadership Shake-Up; Permanent CDER and CBER Chiefs Could Shift Review Priorities

FDA Leadership Shakeup Raises Alarm; DTC Drug Ads Face Sudden Enforcement Shift

In September 2025, President Donald Trump called for stricter enforcement of existing rules on direct-to-consumer (DTC) prescription drug advertising by the U.S. Food and Drug Administration (FDA). Around the same period, HHS Secretary Robert F. Kennedy Jr. also criticized pharmaceutical
  • News
FDA Leadership Shakeup Raises Alarm; DTC Drug Ads Face Sudden Enforcement Shift